Department of Pulmonary Diseases and Tuberculosis
Location: |
Jihlavská 340/20, 625 00 Brno, Pavilion E
Jihlavská 340/20, 625 00 Brno, Pavilion Z Jihlavská 340/20, 625 00 Brno, Pavilion D Correspondence Address: Jihlavská 340/20, 625 00 Brno |
---|
Phone: | +420 532 23 2504 +420 532 23 2554 |
---|---|
E-mail: |
Total number of publications: 18
Articles
-
A narrative review of theophylline: is there still a place for an old friend?
Journal of Thoracic Disease, year: 2024, volume: 16, edition: 5, DOI
-
Adherence to the ISHLT Protocol for the Referral of Patients with Idiopathic Pulmonary Fibrosis to the Transplantation Center among of Czech Centers for Interstitial Lung Diseases
PULMONARY MEDICINE, year: 2024, volume: 2024, edition: June 2024, DOI
-
B cell subsets reconstitution and immunoglobulin levels in children and adolescents with B non-Hodgkin lymphoma after treatment with single anti CD20 agent dose included in chemotherapeutic protocols: single center and review of the literature
Biomedical Papers, Olomouc: Palacky University, year: 2024, volume: 168, edition: 2, DOI
-
Case report of two adults with F508del/3849+10 kb C > T genotype regaining exocrine pancreatic function following treatment with elexacaftor/tezacaftor/ivacaftor
Journal of Cystic Fibrosis, year: 2024, volume: 23, edition: 4, DOI
-
Comparison of the efficacy of cisplatin and carboplatin in combination with etoposide in firstline treatment of extensive-stage small cell lung cancer in real-world practice in the Czech Republic - a retrospective analysis of patients from the LUCAS project
Biomedical Papers, year: 2024, DOI
-
Impact of PD-L1 Expression on the Overall Survival of Patients With Non-small Cell Lung Cancer Treated With Single-agent Pembrolizumab
In vivo, year: 2024, volume: 38, edition: 5, DOI
-
Improved Nutritional Outcomes and Gastrointestinal Symptoms in Adult Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor
Digestive Diseases, year: 2024, volume: 42, edition: 4, DOI
-
Lifestyle Walking Intervention for Patients With Heart Failure With Reduced Ejection Fraction: The WATCHFUL Trial
Circulation, year: 2024, volume: 149, edition: 3, DOI
-
Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis
Journal of Cystic Fibrosis, year: 2024, volume: 23, edition: 2, DOI
-
New Models for Prediction of Post-Operative Pulmonary Complications in Lung Resection Candidates
ERJ Open Research, year: 2024, DOI